Wipro Consumer Care International (WCCI) has accelerated its acquisition strategy with its 17th acquisition - purchasing TTK Healthcare's Good Home and Eva brands for ₹256 crore in its second deal within three days. According to Mint, this follows Wipro's recent acquisition of S Brands Consumer Care Inc. in the Philippines, signalling an acceleration in its inorganic growth strategy across India and overseas markets. The company reported a 9.3% year-on-year increase in annual gross turnover to ₹11,600 crore for FY26, primarily driven by underlying volume growth, with topline growth reaching 12.7% in the December 2025 quarter. As reported by Mint, Kumar Chander noted that acquisitions work only when valuations match for both seller and buyer, with every acquisition growing in terms of revenues and profitability.
The latest acquisition will add Good Home and Eva brands to Wipro's portfolio, with Good Home generating ₹148 crore in revenue in FY26, accounting for about 17% of TTK Healthcare's annual revenue. According to Mint, these brands will strengthen Wipro's home care portfolio through Good Home while expanding its fragrances business with Eva. The Philippines acquisition added brands including KERATINplus, AlcoPlus, DeoPlus, Empress and Fiona Cologne to Wipro's portfolio, with these brands enjoying strong consumer loyalty and leadership positions across key personal care categories. Kumar Chander described the Philippines acquisition as "our sweet 16" and a doubling down on the country, with the Philippines representing Wipro's third market outside India with revenue exceeding ₹1,000 crore.
Wipro is "doubling down" in home care and foods in India, with home care contributing about 15% of Wipro Consumer Care's India business and emerging as one of its fastest-growing segments. As reported by Mint, home care grew 27% last year and another 41% in the first quarter of FY27. Neeraj Khatri noted that Good Home strengthens Wipro's footprint across household cleaning while giving them a strong play in the mass-market air care segment, with India's ₹2,000-crore air care market growing at 12-15% annually. Eva complements Wipro's existing Yardley franchise by helping target younger consumers, as Yardley is largely focused on consumers aged 25 years and above, while Eva addresses teenagers and younger women in the same fragrance and deodorant categories. Good Home operates as a home care brand with a portfolio spanning air care, odour removers, scrubbers and drain cleaners, while EVA operates in deodorant, body sprays, no-gas perfumes, underarm roll-ons and talcum powders.
According to Mint interview with Kumar Chander, strong rural demand and GST rate cuts helped push the annual gross turnover to ₹11,600 crore. Chander noted that luckily, the demand environment has been seeing an uptick in the last six to nine months, both in India and our international markets. Urban demand has been picking up as well, ever since the government slashed Goods and Services Tax (GST) rates on packaged consumer goods, with premiumisation helping growth. India accounts for 49% of Wipro Consumer Care's business, with international markets led by Malaysia, China, and now the Philippines accounting for the remaining 51%. The company sees opportunities to take products to overseas markets, particularly air care across Southeast Asia, South Africa and China. TTK Healthcare Executive Chairman TT Raghunathan noted that Good Home and Eva have been "an integral part of our portfolio and have earned the trust of consumers over many years" and believes Wipro Consumer Care is well positioned to take these brands to the next stage of growth.
According to the company release, the acquisitions strengthen Wipro's position in key growth markets and complement their existing presence across the region. Kumar Chander emphasized that Wipro will continue evaluating opportunities in India and overseas, particularly across Asia and Africa, while remaining disciplined on valuations. The company highlighted Wipro's proven R&D and innovation capabilities for future consumer offerings. Following the transaction, TTK Healthcare's Consumer Products Division will retain Woodward's Gripe Water and Skore, while continuing to focus on pharmaceuticals, medical devices and other healthcare businesses. The deal is expected to close by September 30, 2026, subject to fulfilment of conditions precedent, as reported by Mint.
